key: cord-0809704-f45c6d86 authors: Lata, Surabhi; Akif, Mohd. title: Comparative protein structure network analysis on 3CL(pro) from SARS‐CoV‐1 and SARS‐CoV‐2 date: 2021-05-22 journal: Proteins DOI: 10.1002/prot.26143 sha: 3198e549295845b80d94f868b03f1498dbcffab7 doc_id: 809704 cord_uid: f45c6d86 The main protease M(pro), 3CL(pro) is an important target from coronaviruses. In spite of having 96% sequence identity among M(pros) from SARS‐CoV‐1 and SARS‐CoV‐2; the inhibitors used to block the activity of SARS‐CoV‐1 M(pro) so far, were found to have differential inhibitory effect on M(pro) of SARS‐CoV‐2. The possible reason could be due to the difference of few amino acids among the peptidases. Since, overall 3‐D crystallographic structure of M(pro) from SARS‐CoV‐1 and SARS‐CoV‐2 is quite similar and mapping a subtle structural variation is seemingly impossible. Hence, we have attempted to study a structural comparison of SARS‐CoV‐1 and SARS‐CoV‐2 M(pro) in apo and inhibitor bound states using protein structure network (PSN) based approach at contacts level. The comparative PSNs analysis of apo M(pros) from SARS‐CoV‐1 and SARS‐CoV‐2 uncovers small but significant local changes occurring near the active site region and distributed throughout the structure. Additionally, we have shown how inhibitor binding perturbs the PSG and the communication pathways in M(pros). Moreover, we have also investigated the network connectivity on the quaternary structure of M(pro) and identified critical residue pairs for complex formation using three centrality measurement parameters along with the modularity analysis. Taken together, these results on the comparative PSN provide an insight into conformational changes that may be used as an additional guidance towards specific drug development. Moreover, we have also investigated the network connectivity on the quaternary structure of M pro and identified critical residue pairs for complex formation using three centrality measurement parameters along with the modularity analysis. Taken together, these results on the comparative PSN provide an insight into conformational changes that may be used as an additional guidance towards specific drug development. 5 It has also been characterized as a very contagious pathogenic virus with rapid transmission capability among human-tohuman that has caused an outbreak of the severe pulmonary diseases in almost 216 countries, resulting approximately 814 438 confirmed deaths globally till date (WHO report, 2020). WHO has coined SARS-CoV-2 causing disease as COVID-19 pandemic and that has now become a global health emergency and expected to have severe ramification on the global economy. Currently, there is no specific treatment available to control COVID-19 pandemic. Efforts are being made towards design of vaccines as well as drugs against COVID-19. In the past, therapies have been developed against SARS-CoV-1 targets such as proteases, helicases and polymerases. Moreover, Immune modulators such as interferons and corticosteroids have also been used as therapeutics. 6 Among the viral targets, main protease (M pro , 3CL pro ) has been designated as an important drug target because of its essential role in the processing of polyprotein translated from the viral RNA. 7, 8 The M pro is a homodimer cysteine protease where each protomer consists of three domains, domain I (residue 8-101), domain II (residues 102-184) and domain III (residues 201-303) and catalytic residues and the substrate binding sites are situated between domains I and II of M pro7 . Recent crystal structure of SARS-CoV-2 M pro9 reveals it's structural similarity with M pro of SARS-CoV-1 and has a high degree of sequence identity (96.1%) among the two. 9 Previous studies showed that HIV-1 protease inhibitors block SARS-CoV-1 M pro . 10 Hence, having a structural similarity to the M pro from SARS-CoV-1 and SARS-CoV-2, the known inhibitors could also impart a similar effect on the M pro of SARS-CoV-2. However, the HIV protease inhibitors show different binding effect on M pro of SARS-CoV-2. 11 One of the HIV protease inhibitors, Lopinavir, was shown to inhibit M pro of SARS-CoV-1, in-vitro. 12 While, none of the HIV inhibitors was able to significantly inhibit M pro of SARS-CoV-2, in-vitro. 13 Other known potent inhibitors such as α-ketoamide and N3 are also reported to have differential inhibition on the activity of M pros from SARS_CoV-1 and SARS-CoV-2. 9, 14, 15 A small rearrangement of protein at the structural level by the substitution of a few amino acids at the substrate binding pockets or allosteric sites, results in changes in internal interactions which may lead to differing patterns of inhibitors sensitivity. 16 Similar might be the case with the M pro from SARS-CoV-2, where few changes in the amino acid sequence in comparison to M pro of SARS-CoV-1, may attribute towards the differential effect on M pros . Since no significant structural changes are noticed at the active site, a subtle change of interactions at the allosteric sites of the proteins may have an effect of sensitivity of the inhibitors. Hence, a protein structure network (PSN) based approach can investigate the negligible conformational changes associated in the protein structure. A PSN mainly depicted on a protein structure as a system of networks that comprises nodes and links. Nodes are represented by amino acids residues and links are represented as long and short range interactions among the nodes. Interestingly, this method identifies small changes in structures of protein which are otherwise not easily detectable. [17] [18] [19] Moreover, similar methods have already been implicated in investigating various features of a protein such structural flexibility, 20 protein domain folding, 21 key residue in folding, 22 structural pattern, 23 cluster of residue flexibility 24 and identification of functional residues. 25 Similarly, a PSN-ENM based method has also been used to construct a PSN on a protein 3-D structure by integrating the information from systems dynamic supplied from the Elastic Network mode analysis (ENM-NMA). 26 A global (average) network parameters generated from these methods reveal diminutive structural changes among proteins. In order to probe subtle conformational changes occurring due to differences of few amino acids in the M pro sequences, alteration of local contacts as well as residue specific network parameters were investigated on the structures of M pro (apo and inhibitor bound states) from both SARS-CoV-1 and SARS-CoV-2 by using the PSN and PSN-EMA methods. Recently, topological interaction properties of M pro were analyzed. 27 In another similar study, an analysis of changes in residue interactions of M pro when bound to N3 inhibitor was also investigated. 28 However, in both the cases, monomeric unit of M pro was considered for the analysis. While, it is well known that a biological active M pro molecule exists as a dimer. In fact, as reported earlier that the subunits interfacial region of the M pro can be a possible target for a rational drug design against the SARS-CoV. 29, 30 Hence, it is essential to understand the network connectivity in the biologically active state. Here, we analyzed a comparative PSN in both the proteases (in a biological active state). Our PSN study showed differences in contacts and communication patterns in M pro of SARS-CoV-2 as compared to M pro of SARS-CoV-1. Further, we elucidated the negligible changes throughout the protein structure by quantifying their residues connectivity pattern and mapped the network parameters on 3D structures of protein. We also applied a graph theory centrality concept such as betweeness, closeness, hubs and modularity to highlight critical residues for complex formation. This study will provide an understanding about the sensitivity and effectiveness of the existing inhibitors and this would further be helpful to design specific inhibitors. The 3-D coordinates of 3CL pro were downloaded from Protein Data Bank (1Z1I 31 & 6M03 for apo M pro of SARS-CoV-1 & 2, respectively; 5 N19 & 6Y2G 9 for the inhibitor bound complex of M pro from SARS-CoV-1 & 2, respectively). Here, C alpha atom of amino acid residues is considered as a node and it forms an edge with another C alpha atom if the distance cutoff is 7 Å. Edge weighted C alpha network that is based on Euclidean distance was constructed using NAPS 32 and protein network global parameters such as Degree, Betweeness Centrality, and Clustering Coefficient were analyzed. Degree Degree is total number of direct links between two connected nodes where C alpha atom were considered as contact type. The average degree (D) of a network with N nodes can be computed as D ¼ Di: Hubs are nodes with higher degrees. Shortest path length (SPL) is the minimum number of links required to span through one node to another in a protein topological network. Clustering coefficient (CC) computes the cliquishness for each node in a protein network graph. Cliquishness is defined with respect to total possible edges between them. CC varies between 0 (for no clustering) and 1 (for maximum clustering). Betweenness centrality (BC) is a centrality measurement in a network graph which is based on the total number of shortest path passing between connected nodes in such a way that edges passing for weighted graphs is minimized. Closeness centrality (CCen) represents the closeness of a node to other nodes. It is centrality measurement which calculates the sum of the shortest path. Community or modularity is the region in a network where nodes are more connected to each other. PSN and elastic network model-normal mode analysis (ENM-NMA) approaches were used for long-space communication and effect of allostery on network connectivity. [33] [34] [35] Previously, the ENM-NMA approach for PSN was applied to characterize the topological and allosteric communication pathways in proteins. 36 Other network parameters such as hubs, community, and structural communication analysis were analyzed using a mixed PSN ENM-NMA approach implemented in WebPSN. 26 It constructs Protein Structure Graph (PSG) based on interaction strength of two connected where interaction percentage (Iij) of nodes i and j represents the number of side chain atoms pairs with given cut off (4.5 Å), Ni and Nj are normalization factors. [37] [38] [39] The interaction strength (represented as percent) between residues i and j (I ij ) is calculated for all node pairs. If I ij is more than the minimum interaction strength cutoff (I min ) among the residue pairs, then is considered to be interacting and hence represented as a connection in the PSG. It builds PSG on atomic cross-correlation motions using ENM-NMA. 39 All network parameters were visualized using PYMOL. (Table S1 and Table S2 ). Moreover, these observations on the change in the network parameters suggested their effect on the local conformations of M pros , which is assumed to provide an insight into the sensitivity and selectivity of inhibitors. The PSG of SARS-CoV-1 M pro inhibitor bound complex is richer in nodes, links as well as hubs compared to its unbound state ( Table 3) . Binding of inhibitors to the M pro generated many hubs at the inhibitor binding site and these hubs are associated with residues such as H41, Y54, F140, S144, H163, H172, and Q192. Additionally, inhibitor complex specific hubs are also formed between the interface of domain I & II (residues C16, Y101, F150, and L115), while invariant hubs spanned throughout the structure. Interestingly, similar trends for nodes and links were not observed for SARS-CoV-2 M pro inhibitor bound complexes when compared with apo form of the same (Table 3) . However, the total number of hub residues in the apo form of SARS-CoV-2 M pro was found to be 36, whereas the inhibitor complex of the same possesses 35 hub residues. Few hubs are found to be unique in each structure, suggesting their role towards the specificity of inhibitors. Unlike SARS-CoV-1, the residue H41 and Q192 from SARS-CoV-2 M pro inhibitor complex form do not participate in the active site hubs formation. We mapped the perturbations on the 3-D structure which considers nodes and links unique to each structure ( Figure 3A and without inhibitor N3. 28 Similarly, a recent study on topologies of M pros by PCN methods highlights sensitive structural perturbations. It has been known that biologically active SARS-CoV M pro exists as a dimer. Previously, mutagenesis of E290A in SARS-CoV-2 M pro reported loss of catalytic activity, indicating importance of domain III in dimerization. 40 Hence, In order to highlight structural differences T A B L E 3 Network components and its parameters for both SARS-CoV-1 and SARS-CoV-2 M pro monomer in apo and holo states and M pro dimer in apo state (Table 1) . So, we further evaluated the previously mentioned network components like links, hubs, and link mediated hubs. Interestingly, these parameters were observed to be slightly higher for SARS-CoV-1 dimeric form (Table 3) The BC for each residue of M pro from SARS-CoV-1 as well as SARS-CoV-2 dimeric complexes was analyzed and residues with high BC are listed in (Table S3) The authors declare no conflict of interest regarding this work. Surabhi Lata and Mohd. Akif conceptualize the study, Surabhi Lata performed the study and analyzed the data. Mohd. Akif supervised the study, Surabhi Lata wrote the manuscript and Mohd. Akif reviewed and edited the manuscript. The peer review history for this article is available at https://publons. com/publon/10.1002/prot.26143. The data that support the findings of this study are available from the corresponding author upon reasonable request. Mohd. Akif https://orcid.org/0000-0001-8462-7166 Origin and evolution of pathogenic coronaviruses Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China A novel coronavirus associated with severe acute respiratory syndrome Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia A new coronavirus associated with human respiratory disease in China Coronaviruses-drug discovery and therapeutic options Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza Unrevealing sequence and structural features of novel coronavirus using in silico approaches: the main protease as molecular target Small molecules targeting severe acute respiratory syndrome human coronavirus Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors Production of authentic SARS-CoV Mpro with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction Four amino acid changes in HIV-2 protease confer class-wide sensitivity to protease inhibitors Uncoupling of an ammonia channel as a mechanism of allosteric inhibition in anthranilate synthase of Serratia marcescens: dynamic and graph theoretical analysis Thermostability of in vitro evolved bacillus subtilis lipase a: a network and dynamics perspective complex network analysis of thermostable mutants of Bacillus subtilis lipase A Protein flexibility predictions using graph theory Topological determinants of protein folding Functional sites in protein families uncovered via an objective and automated graph theoretic approach Small-world view of the amino acids that play a key role in protein folding Small-world communication of residues and significance for protein dynamics Network analysis of protein structures identifies functional residues WebPSN: a web server for high-throughput investigation of structural communication in biomacromolecules Topological analysis of SARS CoV-2 main protease SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3 Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme. Defining the extra domain as a new target for design of highly specific protease inhibitors Mechanism of the maturation process of SARS-CoV 3CL protease NAPS: network analysis of protein structures Complex networks: structure and dynamics Long-range correlation in protein dynamics: confirmation by structural data and normal mode analysis Structural resemblance between the families of bacterial signal-transduction proteins and of G proteins revealed by graph theoretical techniques A mixed protein structure network and elastic network model approach to predict the structural communication in biomolecular systems: the PDZ2 domain from tyrosine phosphatase 1E as a case study Identification of side-chain clusters in protein structures by a graph spectral method A network representation of protein structures: implications for protein stability 0: a webserver to infer fingerprints of structural communication in biomacromolecules Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CLpro Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure Comparative protein structure network analysis on 3CL pro from SARS-CoV-1 and SARS-CoV-2